Klaus Hermann

Klaus Hermann is a seasoned Senior Medical Writer with extensive experience in the pharmaceutical and biotech industries, currently employed at Lotus CRO since October 2023. Prior roles include freelance consultancy with ClinCoRep, focusing on protocols for investigational medicinal products in oncology and cardiovascular medicine. Previous positions at bluebird bio, AbbVie, Biogen, Sarepta Therapeutics, Teva Pharmaceuticals, and Insmed Incorporated highlight a strong background in clinical study reports, regulatory writing, and document quality control. Educational qualifications encompass a Habilitation in Experimental Medicine from the University of Hamburg, a postdoctoral fellowship at the University of Florida, and a PhD in Pharmacology from Heidelberg University, complemented by a BSc in Pharmacy from the University of Freiburg.